May 2020
BioWorld
Novartis, Sarepta join Dyno’s enterprise to boldly go to new gene therapy frontier

C&E News
Novartis and Sarepta tap Dyno Therapeutics to use machine learning for gene therapy

Endpoints
Spun out of George Church’s lab, this biotech upstart is mapping the AAV universe for Novartis, Sarepta to gaze

December 2019
Biospace
Dyno Therapeutics Launches to Improve Viral Vectors for Gene Therapy

BioWorld
Dyno to scale the heights of AAV vector engineering

Genetic Engineering News
AAV Optimization on the Fast-Track Hopes to Advance Gene Therapies

November 2019
Chemical and Engineering News
George Church lab spin-off Dyno Therapeutics to use machine learning for gene therapy